F. Brunet‐Possenti

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 312 citations · Full text

Life Sciences, Immunology, Oncology +16

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma

C. Mignard, Aurélie Deschamps Huvier, André Gillibert et al. · Journal of Oncology · 2018 · 82 citations · Full text

Medicine, Dermatology, Oncology +17

HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma

Gabrielle Sonigo, Maxime Battistella, M. Beylot‐Barry et al. · Blood · 2020 · 57 citations · Full text

Medicine, Hematology, Immunology +11

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group

C. Hober, Lisa Fredeau, Anne Pham‐Ledard et al. · Cancers · 2021 · 57 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study

Henri Montaudié, Julien Viotti, P. Combemale et al. · Oncotarget · 2020 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17